Request for COVID Vaccine Prioritization

Life Science Washington submitted the letter below to theWashington Department of Health requesting that two groups of high-risk essential life science employees be prioritized for early access to COVID-19 vaccines.  Our letter is consistent with BIO and AdvaMed requests for prioritization in the CDC’s Advisory Council on Immunization Practices (ACIP) framework.

Access the letter here.

Posted on Updated:
Share:
Related Resources
  • Policy Blog
  • 2026

Policy Blog – August 13, 2026 – Industry Welcomes New PDUFA VIII Agreement

The FDA and biopharmaceutical industry have reached an important agreement on the next iteration of the Prescription Drug User Fee Act (PDUFA), setting the stage for congressional reauthorization of a program that has been central to the FDA’s drug review process for more than three decades.  The FDA recently released its proposed PDUFA VIII commitment letter, outlining […]
  • Industry Reports
  • 2026

Washington State Life Science Investment Report – June 2026
  • Industry Reports
  • 2026

Washington State Life Science Investment Report – May 2026
  • Industry Reports
  • 2026

Washington State Investment Report – April 2026